AngioDynamics, Inc. (ANGO) earnings: date, estimates, results and stock reactions
Next earnings: Q2 FY2027 on 2027-01-06 (expected, time not announced). EPS estimate -0.11, revenue estimate 84.2M.
Over the last 12 reports the stock moved 16.1% on average (either way), rising 6 times and falling 6. EPS beat estimates 10 of 12 times; revenue 7 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q1 FY2027 | 2026-10-08 | -0.04 | -0.11 | +64.4% | 80.9M | 80.5M | -18.8% |
| Q4 FY2026 | 2026-07-14 | -0.07 | -0.11 | +36.4% | 86.6M | 80.2M | +13.2% |
| Q3 FY2026 | 2026-04-02 | -0.07 | -0.11 | +36.4% | 78.4M | 76.8M | -17.6% |
| Q2 FY2026 | 2026-01-06 | -0.15 | -0.10 | -50.0% | 79.4M | 76.4M | -17.5% |
| Q1 FY2026 | 2025-10-02 | -0.10 | -0.14 | +28.6% | 75.7M | 76.3M | +5.1% |
| Q4 FY2025 | 2025-07-15 | -0.03 | -0.13 | +76.9% | 80.2M | 74.3M | -10.7% |
| Q3 FY2025 | 2025-04-02 | 0.03 | -0.13 | +123.1% | 72.0M | 74.3M | +1.7% |
| Q2 FY2025 | 2025-01-08 | -0.04 | -0.11 | +63.6% | 72.8M | 70.6M | +30.9% |